The synthesis of doxercalciferol (1α-hydroxyvitamin D₂) usually starts with vitamin D₂ (ergocalciferol) as the starting material and introduces the 1α-hydroxyl group through selective protection, oxidation, and photoisomerization.
Using vitamin D₂ as the starting material, selective protection is first applied to the 1α and 3β hydroxyl groups of the A ring (for example, using TBSCl to form a 1,3-bi-TBS ether intermediate, CAS 111594-58-2), then performing ring opening or oxidative modification near the C9–C10 bond (such as hydroxylation at specific sites using SeO₂ or peroxy acid), followed by deprotection and key photoisomerization reactions (usually under ultraviolet light irradiation to open the B ring and rearrange it to form a 1α group, 3β-diol structural degree calciferol).
Patent CN115974743B adopts a seven-step process of “cyclization – silicon ether protection – ring opening – oxidation – deprotection – photoisomerization,” emphasizing light exposure after protection to obtain high-purity solid intermediates, improving yield and purification.
Early methods (such as the 2009 literature) attempted a five-step process of esterification–cyclization–oxidation–ring opening–purification, but side reactions had to be avoided.
The vitamin D backbone is sensitive to light, heat, and acids. Stereoselective hydroxylation at the 1α position is difficult to achieve directly, so precursor protection strategies and B-ring photosensitive ring-opening rearrangement (similar to natural vitamin D₃ photochemical synthesis mechanisms) are often relied upon, rather than direct C–H activation hydroxylation.
Some studies have explored multi-step synthesis starting from ergosterol, but due to lengthy steps and low yields, the vitamin D₂ derivation route remains mainstream.
In recent years, there have been attempts at biocatalysis or total synthesis, but no industrial applications have been seen.
Calciferol has no natural direct source and is an artificially synthesized vitamin D₂ analog. Its structure requires specific (1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol configuration, and strict control of stereochemistry and double bond geometry is required during synthesis.
In actual production, intermediate purification and light reaction conditions (wavelength, solvent, oxygen content) are the core steps determining yield and purity.
